Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APAM: Amiloride for Prophylaxis of Migraine With Aura
2017-001288-18Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of amiloride in migraine with aura, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Number of aura episodes. Started Nov 2018; status: active.
02
Drugs
amiloride
03
Conditions
migraine with aura
Beyond the preview
Go deeper on 2017-001288-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001288-18.